KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Income from Non-Controlling Interests (2021 - 2025)

Adaptive Biotechnologies' Income from Non-Controlling Interests history spans 5 years, with the latest figure at $21000.0 for Q2 2025.

  • For Q2 2025, Income from Non-Controlling Interests rose 180.77% year-over-year to $21000.0; the TTM value through Jun 2025 reached -$8000.0, up 92.31%, while the annual FY2025 figure was $42000.0, 140.78% up from the prior year.
  • Income from Non-Controlling Interests for Q2 2025 was $21000.0 at Adaptive Biotechnologies, down from $22000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $76000.0 in Q4 2021 and bottomed at -$95000.0 in Q3 2021.
  • The 5-year median for Income from Non-Controlling Interests is -$26000.0 (2023), against an average of -$19375.0.
  • The largest annual shift saw Income from Non-Controlling Interests crashed 2500.0% in 2024 before it surged 184.62% in 2025.
  • A 5-year view of Income from Non-Controlling Interests shows it stood at $76000.0 in 2021, then tumbled by 153.95% to -$41000.0 in 2022, then surged by 36.59% to -$26000.0 in 2023, then grew by 3.85% to -$25000.0 in 2024, then surged by 184.0% to $21000.0 in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Income from Non-Controlling Interests are $21000.0 (Q2 2025), $22000.0 (Q1 2025), and -$25000.0 (Q4 2024).